Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Más filtros













Base de datos
Intervalo de año de publicación
1.
Artículo en Inglés | MEDLINE | ID: mdl-38801987

RESUMEN

Skeletal dysplasias are a group of heritable diseases in which the bone and cartilage are affected. Despite their impact in anatomical structures, there are many gaps in knowledge between the relationship between skeletal dysplasias and minimal invasive gynecologic surgery. Here, we present a case of a 44-year-old patient with a history of skeletal dysplasia and abnormal uterine bleeding, due to uterine fibroids. As medical treatment failed, a laparoscopic surgery was performed. As expected, normal anatomical landmarks used in laparoscopy were lost as a result of severe scoliosis. Despite anesthesic and surgical difficulties, a successful total laparoscopic hysterectomy and bilateral salpingectomy was performed. Patients with these disorders need to have an individualized and interdisciplinary approach in gynecologic laparoscopic surgery.

2.
J Assist Reprod Genet ; 41(4): 989-998, 2024 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-38315420

RESUMEN

A systematic review and meta-analysis were performed to identify if there is a subset of patients with POI who are more likely to show follicular growth after ovarian fragmentation for follicular activation (OFFA) or in vitro activation (IVA). Five studies met inclusion criteria for meta-analysis with a total of 164 patients. Forty-three patients showed follicle development (26.21%). Of those, the pregnancy rate was 35.58% (11/43) and the live birth rate was 20.93% (9/43). Our meta-analysis showed that age was not associated with follicle growth. However, lower baseline FSH, lower duration of amenorrhea/diagnosis, and presence of follicles remaining in biopsy were statistically significant for follicle development. Patients with basal characteristics mentioned before may have more chances to show follicle growth after OFFA or IVA. Taking into account that approximately 20% of patients with follicle growth had live birth, these results are very promising. Given the overall certainty of evidence, future studies are needed to confirm said results.


Asunto(s)
Fertilización In Vitro , Folículo Ovárico , Inducción de la Ovulación , Índice de Embarazo , Humanos , Femenino , Folículo Ovárico/crecimiento & desarrollo , Folículo Ovárico/patología , Embarazo , Inducción de la Ovulación/métodos , Fertilización In Vitro/métodos , Nacimiento Vivo/epidemiología , Insuficiencia Ovárica Primaria/patología , Hormona Folículo Estimulante
3.
Clin Transplant ; 38(1): e15222, 2024 01.
Artículo en Inglés | MEDLINE | ID: mdl-38064310

RESUMEN

BACKGROUND: Hepatocellular carcinoma (HCC) is a significant cause of oncologic mortality worldwide. Liver transplantation represents a curative option for patients with significant liver dysfunction and absence of metastases. However, this therapeutic option is associated with significant blood loss and frequently requires various transfusions and intraoperative blood salvage for autotransfusion (IBS-AT) with or without a leukocyte reduction filter. This study aimed to analyze available evidence on long-term oncologic outcomes of patients undergoing liver transplantation for HCC with and without IBS-AT. METHODS: Per PRISMA guidelines, a systematic review of keywords "Blood Salvage," "Auto-transfusion," "Hepatocellular carcinoma," and "Liver-transplant" was conducted in PubMed, EMBASE, and SCOPUS. Studies comparing operative and postoperative outcomes were screened and analyzed for review. RESULTS: Twelve studies totaling 1704 participants were included for analysis. Length of stay, recurrence rates, and overall survival were not different between IBS-AT group and non IBS-AT group. CONCLUSION: IBS-AT use is not associated with increased risk of recurrence in liver transplant for HCC even without leukocyte filtration. Both operative and postoperative outcomes are similar between groups. Comparison of analyzed studies suggest that IBS-AT is safe for use during liver transplant for HCC.


Asunto(s)
Carcinoma Hepatocelular , Síndrome del Colon Irritable , Neoplasias Hepáticas , Trasplante de Hígado , Humanos , Carcinoma Hepatocelular/patología , Neoplasias Hepáticas/patología , Transfusión de Sangre Autóloga/efectos adversos , Trasplante de Hígado/efectos adversos , Síndrome del Colon Irritable/etiología , Recurrencia Local de Neoplasia/etiología , Recurrencia Local de Neoplasia/cirugía , Estudios Retrospectivos
4.
Pediatr Surg Int ; 37(11): 1477-1487, 2021 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-34269866

RESUMEN

Hepatoportoenterostomy remains the cornerstone of treatment for biliary atresia. Current employed techniques include laparoscopy and open surgery. This study aims to determine if either method provides an advantage. Following PRISMA guidelines, a systematic review was conducted. Nineteen studies were included. Mean operative time 34.98 (95% CI 20.10, 49.85; p ≤ 0.00001) was longer in laparoscopic while bleeding volumes - 16.63 (95% CI - 23.39, - 9.86; p ≤ 0.00001) as well as the time to normal diet - 2.42 (95% CI - 4.51, - 0.32; p = 0.02) were lower in the laparoscopic group. No differences were observed in mean length of stay - 0.83. Similar complication, transfusions, postoperative cholangitis 0.97, and transplant free survival rates 1.00 (0.63, 1.60; p = 0.99) were seen between groups. Laparoscopic portoenterostomy provides advantages on operative time and bleeding as well as to normal diet when compared to open procedures. Both procedures showed no differences in length of stay, complications, cholangitis, and importantly, native liver survival. Level of evidence: III.


Asunto(s)
Atresia Biliar , Laparoscopía , Atresia Biliar/cirugía , Humanos , Lactante , Tempo Operativo , Portoenterostomía Hepática , Resultado del Tratamiento
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA